Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 700.30
+4.80 (0.69%)
At close: Jan 9, 2026
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 208.95 million as of January 9, 2026. Its market cap has decreased by -33.34% in one year.
Market Cap
208.95M
Enterprise Value
162.50M
Revenue
n/a
Ranking
n/a
PE Ratio
189.42
Stock Price
700.30
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 208.95M, a decrease of -82.67%. That is a compound annual growth rate of -34.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 208.95M | 14.67% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 115.77B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |